Manufacturers Life Insurance Company, The Igm Biosciences, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 72,155 shares of IGMS stock, worth $97,409. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,155
Previous 74,612
3.29%
Holding current value
$97,409
Previous $1.23 Million
64.34%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding IGMS
# of Institutions
86Shares Held
19.5MCall Options Held
61.3KPut Options Held
36.7K-
Baker Bros. Advisors LP New York, NY4.09MShares$5.53 Million0.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$4.82 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$4.5 Million0.9% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.99 Million1.41% of portfolio
-
Goldman Sachs Group Inc New York, NY978KShares$1.32 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $39.1M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...